Meaning
Laboratory simulation protocols measure the bioaccessibility and chemical transformation of food-contact polymer migrants passing through synthetic human gastrointestinal fluids. Performing an in vitro digestion assay exposes polymer additives, oligomers, and microplastic particles to sequential gastric and intestinal enzyme solutions at controlled body temperatures. The technique quantifies how much embedded substance releases from a plastic matrix into bioaccessible fractions during human digestion.
Regulatory compliance assessments rely on these assays to evaluate health risks without animal testing.
Gastrointestinal Simulation
Multi-stage incubation vessels mimic the sequential physiological conditions of the mouth, stomach, and small intestine using synthetic saliva, pepsin, and bile salts. Hydrochloric acid lowers the gastric stage pH to approximately two, inducing potential chemical breakdown of migrating oligomers or stabilizer compounds. Applying in vitro digestion methodologies reveals whether complex plastic additives cleave into toxic monomeric subunits under acidic and enzymatic stress.
Fluid sampling at defined time intervals isolates solubilized fractions from remaining polymer solids.
Migration Bioaccessibility
Chemical substances embedded in food-contact plastics exhibit variable release rates depending on matrix swelling and surfactant actions from bile salts. Solubilized migrants partition into the aqueous phase, where analytical instruments measure their chemical structure and total mass. Matrix entrapment limits total bioaccessibility for high molecular weight polymers.
Assay Boundary
Static enzyme systems cannot fully replicate physiological peristalsis or active intestinal wall absorption mechanisms. Hydrophobic molecules often adsorb onto plastic incubation vessel walls, requiring solvent extraction validation steps to avoid underestimating migrant concentrations. The protocol applies to non-volatile migrants and stops short of predicting systemic metabolic toxicity.
